Literature DB >> 1548079

Effects of Actinobacillus pleuropneumoniae hemolysin on porcine neutrophil function.

F A Udeze1, S Kadis.   

Abstract

In an attempt to gain insight into the events that take place during Actinobacillus pleuropneumoniae infection, the present study was designed to ascertain the effects of bacterial toxicity on porcine neutrophil functions and viability. Incubation of phagocytes (2 x 10(6)) with opsonized A. pleuropneumoniae 4074 (2 x 10(7) CFU) resulted in phagocytic uptake of less than or equal to 4%. At the same bacterium-to-phagocyte ratio, levels of lactate dehydrogenase activity of 74 and 81% were detected in the extracellular medium after 1.5 and 3 h of incubation, respectively. Furthermore, the ingested bacteria were not killed by the phagocytes. These effects were ascribed to hemolysin produced by the bacteria, because the presence of hemolysin-neutralizing antibody prevented overt cellular damage, significantly increased phagocytic uptake (P less than 0.001), and resulted in an approximately 10-fold decrease in the number of CFU of the ingested bacteria. Cytolytic doses of isolated hemolysin caused dose-related loss of cell viability, diminished bactericidal activity of toxin-treated phagocytes for Escherichia coli, and decreased the ability of the phagocytes to undergo a respiratory burst upon stimulation with phorbol myristic acetate. In contrast, sublytic doses of the hemolysin activated the phagocytes and caused them to respond to phorbol myristic acetate with increased generation of superoxide anion. Because heated (100 degrees C, 5 min) hemolysin preparations did not produce similar effects, we contend that the observed effects were not due to contaminating endotoxin. The data presented herein indicate that A. pleuropneumoniae hemolysin is a potent antiphagocytic virulence factor by virtue of its leukocidal activity. Sublytic doses of the toxin may have important effects on the oxidative metabolism of phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548079      PMCID: PMC257031          DOI: 10.1128/iai.60.4.1558-1567.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Pore-forming cytolysins of gram-negative bacteria.

Authors:  R A Welch
Journal:  Mol Microbiol       Date:  1991-03       Impact factor: 3.501

2.  Use of MTT colorimetric assay to measure cell activation.

Authors:  D Gerlier; N Thomasset
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

3.  Pleuropneumonia of swine caused by Haemophilus parahaemolyticus. Studies on the protection obtained by vaccination.

Authors:  R Nielsen
Journal:  Nord Vet Med       Date:  1976 Jul-Aug

4.  Growth and hemolysin production by Haemophilus pleuropneumoniae cultivated in a chemically defined medium.

Authors:  J R Maudsley; S Kadis
Journal:  Can J Microbiol       Date:  1986-10       Impact factor: 2.419

5.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  Role of haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia.

Authors:  F A Udeze; K S Latimer; S Kadis
Journal:  Am J Vet Res       Date:  1987-05       Impact factor: 1.156

7.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Sequential study of lesion development in experimental haemophilus pleuropneumonia.

Authors:  A D Liggett; L R Harrison; R L Farrell
Journal:  Res Vet Sci       Date:  1987-03       Impact factor: 2.534

9.  Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  S Rosendal; J Devenish; J I MacInnes; J H Lumsden; S Watson; H Xun
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

10.  Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs.

Authors:  B W Fenwick; B I Osburn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more
  6 in total

1.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Secreted proteases from Actinobacillus pleuropneumoniae serotype 1 degrade porcine gelatin, hemoglobin and immunoglobulin A.

Authors:  E Negrete-Abascal; V R Tenorio; J J Serrano; C Garcia; M de la Garza
Journal:  Can J Vet Res       Date:  1994-04       Impact factor: 1.310

3.  [Cu,Zn]-Superoxide dismutase mutants of the swine pathogen Actinobacillus pleuropneumoniae are unattenuated in infections of the natural host.

Authors:  B J Sheehan; P R Langford; A N Rycroft; J S Kroll
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.

Authors:  R Jansen; J Briaire; H E Smith; P Dom; F Haesebrouck; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 5.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

6.  Molecular characterization of a common 48-kilodalton outer membrane protein of Actinobacillus pleuropneumoniae.

Authors:  W T Cruz; Y A Nedialkov; B J Thacker; M H Mulks
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.